Damiano Abeni

Dr. Damiano Abeni

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in European Journal of Cancer
Verified
Journal Article
Open access
Sara GandiniSara Gandini
Sara Gandini
FSFrancesco Sera
Francesco Sera
MCMaria Sofia Cattaruzza
Maria Sofia Cattaruzza
PPPaolo Pasquini
Paolo Pasquini
DADamiano Abeni
Damiano Abeni
CMCarmelo Francesco Melchi
Carmelo Francesco Melchi
A systematic meta-analysis of observational studies of melanoma and one of the most important risk factors, the number of naevi, was conducted in order to clarify aspects of the aetiology of this disease. Following a systematic literature search, relative risks (RRs) were extracted from 46 studies published before September 2002. Dose-response random effects models were used to obtain pooled estimates. Sub-group analysis and meta-regression were carried out to explore sources of between-study variation and bias. Sensitivity analyses investigated the reliability of the results and any publication bias. Number of common naevi was confirmed an important risk factor with a substantially increased risk associated with the presence of 101-120 naevi compared with <15 (pooled Relative Risk (RR) = 6.89; 95% Confidential Interval (CI): 4.63, 10.25) as was the number of atypical naevi (RR = 6.36 95%; CI: 3.80, 10.33; for 5 versus 0). The type of study and source of cases and controls were two study characteristics that significantly influenced the estimates. Case-control studies, in particular when the hospital was the source for cases or controls, appeared to present much lower and more precise estimates than cohort studies.

1 November 2000 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
APAngelo Picardi
Angelo Picardi
DADamiano Abeni
Damiano Abeni
CMC.F. Melchi
C.F. Melchi
PPP. Puddu
P. Puddu
PPP. Pasquini
P. Pasquini

9 February 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
LFluca Fania
luca Fania
DDDario Didona
Dario Didona
FPFrancesca Romana Di Pietro
Francesca Romana Di Pietro
SVSofia Verkhovskaia
Sofia Verkhovskaia
RMRoberto Morese
Roberto Morese
EDElena Dellambra
Elena Dellambra
Cutaneous squamous cell carcinoma (cSCC), a non-melanoma skin cancer, is a keratinocyte carcinoma representing one of the most common cancers with an increasing incidence. cSCC could be in situ (e.g., Bowen’s disease) or an invasive form. A significant cSCC risk factor is advanced age, together with cumulative sun exposure, fair skin, prolonged immunosuppression, and previous skin cancer diagnoses. Although most cSCCs can be treated by surgery, a fraction of them recur and metastasize, leading to death. cSCC could arise de novo or be the result of a progression of the actinic keratosis, an in situ carcinoma. The multistage process of cSCC development and progression is characterized by mutations in the genes involved in epidermal homeostasis and by several alterations, such as epigenetic modifications, viral infections, or microenvironmental changes. Thus, cSCC development is a gradual process with several histological- and pathological-defined stages. Dermoscopy and reflectance confocal microscopy enhanced the diagnostic accuracy of cSCC. Surgical excision is the first-line treatment for invasive cSCC. Moreover, radiotherapy may be considered as a primary treatment in patients not candidates for surgery. Extensive studies of cSCC pathogenic mechanisms identified several pharmaceutical targets and allowed the development of new systemic therapies, including immunotherapy with immune checkpoint inhibitors, such as Cemiplimab, and epidermal growth factor receptor inhibitors for metastatic and locally advanced cSCC. Furthermore, the implementation of prevention measures has been useful in patient management.

12 November 2004 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
ESEnrico Scala
Enrico Scala
SPS. Pallotta
S. Pallotta
AFA. Frezzolini
A. Frezzolini
DADamiano Abeni
Damiano Abeni
CBC. Barbieri
C. Barbieri
GRGiandomenico Russo
Giandomenico Russo

1 March 2002 in The Journal of Pediatrics
Verified
Journal Article
Closed access
CDCarlo Dionisi-Vici
Carlo Dionisi-Vici
CRCristiano Rizzo
Cristiano Rizzo
ABAlberto B. Burlina
Alberto B. Burlina
UCUbaldo Caruso
Ubaldo Caruso
GSGaetano Sabetta
Gaetano Sabetta
DADamiano Abeni
Damiano Abeni

20 April 2001 in Psychotherapy and Psychosomatics
Verified
Journal Article
Closed access
APAngelo Picardi
Angelo Picardi
DADamiano Abeni
Damiano Abeni
The possibility of a causal influence of emotional stress, especially of stressful life events, on the course of various skin diseases has long been postulated. Clinical wisdom and experience, as well as many anecdotal observations and uncontrolled case series, support this opinion. We reviewed the available evidence on the role of stressful life events in triggering or exacerbating skin diseases. The role of stressful events in vitiligo, lichen planus, acne, pemphigus and seborrhoeic dermatitis was either controversial or insufficiently explored. The role of stressful events in psoriasis, alopecia areata, atopic dermatitis and urticaria was apparently clearer. However, only a few studies met acceptable methodological standards for stress measurement. Also, few studies considered common potential confounding factors (e.g. age, duration of illness, familial factors), and no study controlled adequately for the influence of other crucial factors (e.g. discontinuation of treatment, seasonal effects). Adding that the large majority of studies were retrospective, it seems wise to conclude that only preliminary evidence has been published so far on the role of stressful life events in bringing on or worsening any dermatological disease. Further research is mandatory, either in the form of prospective studies or, more feasibly, of well-designed case-control studies with adequate statistical power. Future studies should also pay more attention to protective as well as vulnerability factors in stressful events. Further, it would be important to investigate other sources of psychological stress, such as chronic stress and everyday stress. Measuring stress appraisal, although difficult, would also be important.